ALNYLAM PHARMACEUTICALS, INC. Payment for Other Postretirement Benefits
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Payment for Other Postretirement Benefits of -$96.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OtherPostretirementBenefitsPayments · last filed 2012-05-03
- ALNYLAM PHARMACEUTICALS, INC. payment for other postretirement benefits for the quarter ending 2012-03-31 was -$96.00K.
- ALNYLAM PHARMACEUTICALS, INC. payment for other postretirement benefits for the quarter ending 2011-12-31 was -$95.00K.
- ALNYLAM PHARMACEUTICALS, INC. payment for other postretirement benefits for the quarter ending 2011-09-30 was -$119.00K.
- ALNYLAM PHARMACEUTICALS, INC. payment for other postretirement benefits for the quarter ending 2011-06-30 was -$136.00K.
- ALNYLAM PHARMACEUTICALS, INC. payment for other postretirement benefits for fiscal 2011 was -$488.00K.
- ALNYLAM PHARMACEUTICALS, INC. payment for other postretirement benefits for fiscal 2010 was -$495.00K.
- ALNYLAM PHARMACEUTICALS, INC. payment for other postretirement benefits for fiscal 2009 was -$461.00K.
| Period end | Payment for Other Postretirement Benefits 3 month | Payment for Other Postretirement Benefits 6 month | Payment for Other Postretirement Benefits 9 month | Payment for Other Postretirement Benefits 12 month |
|---|---|---|---|---|
| 2012-03-31 | -$96.00K 10-Q · filed 2012-05-03 | -$191.00K derived: sum of 2 quarters · filed 2012-05-03 | -$310.00K derived: sum of 3 quarters · filed 2012-05-03 | -$446.00K derived: sum of 4 quarters · filed 2012-05-03 |
| 2011-12-31 | -$95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | -$214.00K derived: sum of 2 quarters · filed 2012-02-13 | -$350.00K derived: sum of 3 quarters · filed 2012-02-13 | -$488.00K 10-K · filed 2012-02-13 |
| 2011-09-30 | -$119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$255.00K derived: sum of 2 quarters · filed 2011-11-03 | -$393.00K 10-Q · filed 2011-11-03 | -$486.00K derived: sum of 4 quarters · filed 2012-05-03 |
| 2011-06-30 | -$136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | -$274.00K 10-Q · filed 2011-08-03 | -$367.00K derived: sum of 3 quarters · filed 2012-05-03 | -$498.00K derived: sum of 4 quarters · filed 2012-05-03 |
| 2011-03-31 | -$138.00K 10-Q · filed 2012-05-03 | -$231.00K derived: sum of 2 quarters · filed 2012-05-03 | -$362.00K derived: sum of 3 quarters · filed 2012-05-03 | |
| 2010-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | -$224.00K derived: sum of 2 quarters · filed 2012-02-13 | -$495.00K 10-K · filed 2012-02-13 | |
| 2010-09-30 | -$131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$402.00K 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$271.00K 10-Q · filed 2011-08-03 | |||
| 2009-12-31 | -$461.00K 10-K · filed 2012-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |